Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-05
DOI
10.1038/s41420-021-00547-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Dominant Role of Oxygen in Modulating the Chemical Evolution Pathways of Tyrosine in Peptides: Dityrosine or Melanin
- (2019) Xiaokang Ren et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
- (2019) Daehwan Kim et al. NATURE BIOTECHNOLOGY
- L-DOPA causes mitochondrial dysfunction in vitro: A novel mechanism of L-DOPA toxicity uncovered
- (2019) Steven Giannopoulos et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mitochondrial calcium imbalance in Parkinson’s disease
- (2018) Marthe H.R. Ludtmann et al. NEUROSCIENCE LETTERS
- The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease
- (2018) David C. Schöndorf et al. Cell Reports
- Compatibility study between antiparkinsonian drug Levodopa and excipients by FTIR spectroscopy, X-ray diffraction and thermal analysis
- (2017) Ionut Ledeti et al. JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
- Analysis of mitochondrial metabolism in situ : Combining stable isotope labeling with selective permeabilization
- (2017) Yannic Nonnenmacher et al. METABOLIC ENGINEERING
- Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
- (2016) Tara Swart et al. CNS DRUGS
- Converging roles of ion channels, calcium, metabolic stress, and activity pattern ofSubstantia nigradopaminergic neurons in health and Parkinson's disease
- (2016) Johanna Duda et al. JOURNAL OF NEUROCHEMISTRY
- Bioenergetics and redox adaptations of astrocytes to neuronal activity
- (2016) Juan P. Bolaños JOURNAL OF NEUROCHEMISTRY
- Melanin synthesis under oxygen pressure
- (2016) Erika Soares Bronze-Uhle et al. POLYMER INTERNATIONAL
- Regulation of rDNA transcription in response to growth factors, nutrients and energy
- (2015) Eric P. Kusnadi et al. GENE
- PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases
- (2015) Sara Martire et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Normal substantia nigra patients treated with levodopa – Clinical, therapeutic and pathological observations
- (2015) Ali H. Rajput et al. PARKINSONISM & RELATED DISORDERS
- A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging
- (2015) M. Mohrin et al. SCIENCE
- Cell-based assays for Parkinson's disease using differentiated human LUHMES cells
- (2014) Xiao-min Zhang et al. ACTA PHARMACOLOGICA SINICA
- DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis
- (2014) Guangchuang Yu et al. BIOINFORMATICS
- Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons
- (2014) Mohammad-Saeid Jami et al. BMC NEUROSCIENCE
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Pathview: an R/Bioconductor package for pathway-based data integration and visualization
- (2013) Weijun Luo et al. BIOINFORMATICS
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- Complexity of dopamine metabolism
- (2013) Johannes Meiser et al. Cell Communication and Signaling
- Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells
- (2013) Sarah-Maria Fendt et al. Nature Communications
- Protective Effects of L-Dopa and Carbidopa Combined Treatments on Human Catecholaminergic Cells
- (2012) Monica Colamartino et al. DNA AND CELL BIOLOGY
- Dopamine Oxidation and Autophagy
- (2012) Patricia Muñoz et al. Parkinsons Disease
- l-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro
- (2011) Sandra W. Chan et al. EXPERIMENTAL NEUROLOGY
- Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line
- (2011) Diana Scholz et al. JOURNAL OF NEUROCHEMISTRY
- A review of PARP inhibitors: from bench to bedside
- (2010) C. Underhill et al. ANNALS OF ONCOLOGY
- Preventing NAD+ Depletion Protects Neurons against Excitotoxicity
- (2010) Dong Liu et al. Annals of the New York Academy of Sciences
- Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine
- (2010) Michelle Nelson et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mechanisms of L-DOPA-induced cytotoxicity in rat adrenal pheochromocytoma cells: implication of oxidative stress-related kinases and cyclic AMP
- (2010) C.M. Jin et al. NEUROSCIENCE
- MetaboliteDetector: Comprehensive Analysis Tool for Targeted and Nontargeted GC/MS Based Metabolome Analysis
- (2009) Karsten Hiller et al. ANALYTICAL CHEMISTRY
- Regulation of mitochondrial dehydrogenases by calcium ions
- (2009) Richard M. Denton BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
- (2009) Elke Hattingen et al. BRAIN
- Neuroprotective effect of l-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson’s disease: a direct comparison study
- (2009) Jin Young Shin et al. JOURNAL OF NEUROCHEMISTRY
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death
- (2009) Sonia Gandhi et al. MOLECULAR CELL
- The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants
- (2009) Peter J. A. Cock et al. NUCLEIC ACIDS RESEARCH
- AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply
- (2009) S. Hoppe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A review of Parkinson's disease
- (2008) C. A. Davie BRITISH MEDICAL BULLETIN
- Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced Dyskinesias
- (2008) Fabio Blandini et al. CLINICAL NEUROPHARMACOLOGY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira MOVEMENT DISORDERS
- Neutral red uptake assay for the estimation of cell viability/cytotoxicity
- (2008) Guillermo Repetto et al. Nature Protocols
- The PINK1/Parkin pathway regulates mitochondrial morphology
- (2008) A. C. Poole et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation